We showed that DFOM inhibited the migration and invasion of oesophageal cancer cells through multiple mechanisms, including reducing the expression of LCN2 and LLM, suppressing MMP9 enzyme activity, inhibiting cytoskeletal rearrangement, and thus restoring ECM remodelling. The gene discussed is MMP9; the disease is carcinoma of esophagus.